hypertensive%20crisis
HYPERTENSIVE CRISIS
Hypertensive emergency is having severely elevated blood pressure (>180-220 mmHg/120-130 mmHg) that is complicated by progressive target end-organ damage of the central nervous system, heart, kidneys, or the gravid uterus.
There is no definite blood pressure threshold for the diagnosis of hypertensive emergency.
Most target end-organ damage happen with diastolic blood pressure of ≥130 mmHg.
Hypertensive urgency refers to patients with severely elevated blood pressure (>180/110-120 mmHg) but with little or no evidence of acute end-organ damage.
The clinical differentiation between hypertensive emergencies and urgencies is dependent on the presence of target end-organ damage rather than the level of blood pressure.
Drug Information

Indication: HTN.

Indication: HTN. Adjunct to digitalis &/or diuretic therapy in CHF.

Indication: CHD: Chronic stable angina pectoris; HTN.

Indication: HTN; angina pectoris; MI. Disturbances of cardiac rhythm including supraventricular tachycardia. Functional he...

Indication: Control of BP in peri-op HTN. CHF associated w/ acute MI. Angina pectoris unresponsive to recommended doses of...

Dosage: Essential HTN Initially 10-20 mg daily. Maintenance: 20 mg once daily. Max: 40 mg daily. Renovascular HTN Init

Indication: Angina pectoris, CHF.

Indication: Treatment & prophylaxis of angina pectoris & treatment of variant angina.

Indication: Severe HTN in pregnancy. Hypotensive anaesth. Hypertensive episodes following acute MI.

Dosage: HTN 100-400 mg as single or bd dose. Angina pectoris 50-100 mg bd-tds. Cardiac arrhythmias 50 mg bd-tds up to

1  /  4
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Audrey Abella, 07 Oct 2019
Individuals with left main coronary artery disease (CAD) who underwent percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG) continued to show similar rates of the primary outcome (composite of death, stroke, or myocardial infarction), highlighting the potential of PCI as a CABG alternative in this patient setting, according to the final r­esults of the EXCEL* trial presented at TCT 2019.